Effect of RFA combined with TACE for treatment of early hepatocellular carcinoma with liver cirrhosis
10.11659/jjssx.03E015051
- VernacularTitle:RFA联合TACE治疗合并肝硬化的早期肝细胞肝癌的疗效研究
- Author:
Yu WANG
;
Kuansheng MA
;
Jian CHEN
;
Juxian SONG
- Publication Type:Journal Article
- Keywords:
radiofrequency ablation;
transcatheter hepatic arterial chemoembolization;
early hepatocellular carcinoma;
liver cirrhosis
- From:Journal of Regional Anatomy and Operative Surgery
2015;(3):273-276
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the effect of radiofrequency ablation ( RFA) combined with transcatheter hepatic arterial chemoemboli-zation ( TACE) and radiofrequency ablation alone for the treatment of early hepatocellular carcinoma ( HCC) with liver cirrhosis. Methods The data of all the patients that were given RFA+TACE (n=51) and RFA (n=53) treatments in our hospital from January 2008 to De-cember 2013 were analyzed. The demographic data,process of operation,postoperative complications,postoperative recovery and follow-up of the patients in two groups were carefully compared. Results The average follow-up time was (37. 6 ± 20. 7)months,38 cases were dead and 76 cases were survival. The overall survival rates of 1 years,3 years,5 years after operation were respectively 96. 5%,78. 7%,65. 9% in RFA+TACE group and 94. 3%,75. 6%,62. 3% in RFA group. Tumor-free survival rates of 1 years,3 years,5 years were 75. 4%,47. 3%, 32. 6% in RFA+TACE group,and 63. 1%,37. 2%,22. 4% in RFA group. Conclusion For patients with early hepatocellular carcinoma with liver cirrhosis,RFA combined with TACE have higher tumor free survival rate than RFA alone in the treatment of early hepatocellular carcinoma,but no difference in overall survival rate. The results still need to be validated by prospectively randomized controlled trials.
